Cancer survival analysis in Hamburg 1995-2003: Assessing the data quality within a population-based registry

Acta Oncologica

Volumn 48, Issue 1, 2009, Pages 34-43

  Nennecke, Alice L ^a   Hentschel, Stefan ^a   Reintjes, Ralf ^b  

^a Authority for Social Affairs Family Health and Consumer Protection   (Germany)

^b HAMBURG UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER REGISTRY; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; DATA BASE; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; COLONIC NEOPLASMS; DATA INTERPRETATION, STATISTICAL; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PROSTATIC NEOPLASMS; REGISTRIES; SEX FACTORS; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 58149093105     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802199808     Document Type: Article

References (52)

1. Brenner H, Stegmaier C, Ziegler H. Long-term survival of cancer patients in Germany achieved by the beginning of the third millennium. Ann Oncol 2005;16:981-6.
2. Association of Population-Based Cancer Registries in Germany in cooperation with the Robert Koch Institute, editors. In: Cancer in Germany. 5th ed. Saarbrücken, Germany: 2006. Available from: http://www.ekr.med.uni- erlangen.de/GEKID/Doc/kid2006_englisch.pdf
3. Engel J, Eckel R, Aydemir U, Aydemir S, Kerr J, Schlesinger-Raab A, et al. Determinants and prognoses of locoregional and distant progression in breast cancer. Int J Radiat Oncol Biol Phys 2003;55:1186-95.
4. Kerr J, Engel J, Eckel R, Hölzel D. Survival for rectal cancer patients and international comparisons. Ann Oncol 2005;16:664-72.
5. Schlesinger-Raab A, Eckel R, Engel J, Sauer H, Löhrs U, Molls M, et al. Metastasiertes Mammakarzinom: Keine Lebensverlängerung seit 20 Jahren. Dt Ärztebl 2005;102:A2706-A2714.
6. Fietkau R, Zettl H, Klocking S, Kundt G. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry. Strahlenther Onkol 2004;180:478-87.
7. Tumorzentrum Land Brandenburg e.V. und Qualitätskonferenz Onkologie. Qualitätssicherung durch klinische Krebsregister: Sachbericht Onkologie 2004/2005. Frankfurt (Oder) 2006. Available from: http://www.tumorzentrum- brandenburg.de/pwp/(S(urgnipzt5jvjch55qslofra0))/uploads/Sachbericht_2004-2005. pdf
8. Sieveking GH. Das Krebsproblem in der öffentlichen Gesundheitsfürsorge. Zeitschrift für Gesundheitsverwaltung und Gesundheitsfürsorge. 1930;1:23-30.
9. Estève J, Kricker A, Ferlay J, Parkin DM, editors. Facts and figures of cancer in the European Community. International Agency for Research on Cancer 1993. Available from: http://telescan.nki.nl/iarc.html
10. Cancer Registry of Norway, Institute of Population-based Cancer Research. Cancer in Norway 2004. Oslo. Available from: http://www.kreftregisteret.no/ forekomst_og_overlevelse_2004/kreft_i_norge_2004web.pdf
11. Centre for Epidemiology, National Board of Health and Welfare. Cancer patient survival in Sweden 1980-2002. 2004. Published at and available from: www.sos.se/epc/publikationer/nyartikel/cancersurvival/cancerpatientsurvival.htm
12. Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research. Cancer in Finland 2002 and 2003. Helsinki 2005. Available from: http://www.cancerregistry.fi/eng/statistics/index_7.pdf
13. Integraal Kankercentrum Amsterdam. Overlevingscijfers IKA-regio (Noord-Holland and Flevoland) Last update 16-04-2007. Available from: http://www.ikcnet.nl/IKA/index.php?id=1735&nav_id=160®io_id=117
14. National Statistics. Cancer Survival, England, 1999-2004. Last update 21-08-2007. Available from: http://www.statistics.gov.uk/downloads/theme_health/ Survival_21_sites_1999_2003_by_age_group_v6.xls
15. Brenner H, Hakulinen T. Population-based monitoring of cancer patient survival in situations with imperfect completeness of cancer registration. Br J Cancer 2005;92:576-9.
16. Colonna M, Grosclaude P, Faivre J, Revzani A, Arveux P, Chaplain G, et al. Cancer registry data based estimation of regional cancer incidence: Application to breast and colorectal cancer in French administrative regions. J Epidemiol Community Health 1999;53:558-64.
17. Haberland J, Schön D, Bertz J, Görsch B. Vollzä hligkeitsschätzungen von Krebsregisterdaten in Deutschland. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 2003;46:770-4.
18. Percy C, van Holten V, Muir C, editors. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization; 1990.
19. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. editors. International classification of diseases for oncology. Geneva: World Health Organization; 2000.
20. Berkson J, Gage RP. Calculation of survival rates for cancer. Proceedings of Staff Meetings of the Mayo Clinic 1950;25:270-86.
21. Cutler SJ, Ederer F. Maximum utilisation of the life table method in analyzing survival. J Chron Dis 1958;8:699-712.
22. Voutilainen ET, Dickman PW, Hakulinen T. SURV2: Relative survival analysis program. Software Manual Program version 2.02β. Helsinki 1998, Manual updated August 9, 2000. Available from: http://www.cancerregistry.fi/ surv2/manual.pdf
23. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: A statistical methodology. Natl Cancer Inst Monogr 1961; 6:101-121.
24. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38:933-42.
25. Manton KG, Stallard E, Woodbury MA, Dowd JE. Time-varying covariates in models of human mortality and aging: Multidimensional generalizations of the Gompertz. J Gerontol A Biol Sci Med Sci 1994;49:B169-B190.
26. Greenwood M. The errors of sampling of the survivorship tables. reports on public health and medical subjects. 1926;33:1-30.
27. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307-16.
28. Hakulinen T, Gibberd R, Abeywickrama K, Söderman B. A computer program package for cancer survival studies. Cancer Society of Finland Publication No. 39, Helsinki: Finnish Cancer Registry, 1988.
29. Finnish Cancer Registry. SURV3: Windows software for relative survival analysis (version 3.01), last update December 20, 2002. Available from: http://www.cancerregistry.fi/surv3/
30. Teppo L, Dickman PW, Hakulinen T, Luostarinen T, Pukkala E, Sankila R, et al. Cancer patient survival-patterns, comparisons, trends - a population-based Cancer Registry study in Finland. Acta Oncol 1999;38:283-94.
31. Levi F, Randimbison L, Te VC, Franceschi S, La Vecchia C. Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993. Ann Oncol 2000;11:957-63.
32. Capocaccia R, Gatta G, Roazzi P, Carrani E, Santaquilani M, De Angelis R, et al. The EUROCARE-3 database: Methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol 2003;14(Suppl 5):v14-v27.
33. Berrino F, De Angelis R, Sant M, Rosso S, Lasota MB, Coebergh JW, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-1999: Results of the EUROCARE-4 study. Lancet Oncol 2007;8:773-83.
34. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al., editors. Cancer incidence in five continents Vol. IX. IARC Scientific Publications No 160, Lyon, IARC.
35. Blum K, Müller U. Dokumentationsaufwand im ärztlichen Dienst der Krankenhäuser. Bestandsaufnahme und Verbesserungsvorschläge. Düsseldorf: Deutsche Krankenhaus Verlagsgesellschaft; 2003.
36. Becker N, Brenner H, Klug SJ, Schilling FH, Spix C. Beiträge der Epidemiologie zur Krebsfrüherkennung DOI 10.1007/s00761-006-1127-2; Onkologe 2006 online.
37. Neuhaus H. Vorsorge zur Prävention oder Früherkennung des kolorektalen Karzinoms. Dt Ärztebl 1998;95:A530-A537.
38. th Oct 2004. Available from: http://www.krebsregister-niedersachsen.de/registerstelle/dateien/Vortrag3. pdf
39. Merzenich H, Giersiepen K, Kieschke J, Zeeb H. Früherkennung kolorektaler Tumoren: Gibt es die optimale Screeningmaßnahme? Gesundheitswesen 2005;67:803-8.
40. Joensuu H, Toikkanen S. Cured of breast cancer? J Clin Oncol 1995;13:62-9.
41. Stenbeck M, Rosén M, Holm LE. Cancer survival in Sweden during three decade, 1961-1991. Acta Oncol 1995;34:881-91.
42. st ed. Baden-Baden: Nomos Verlagsgesellschaft; 1998. Available from: http://gripsdb.dimdi.de/de/hta/ hta_berichte/hta003_bericht_de.pdf
43. Nekolla EA, Griebel J, Brix G. Introduction of a mammography screening program in Germany - Benefit-risk considerations. Der Radiologe 2005;45:245-54.
44. Kato I, Severson RK, Schwartz AG. Conditional median survival of patients with advanced carcinoma: Surveillance, epidemiology, and end results data. Cancer 2001;92:2211-9.
45. Lynge E, Olsen AH, Fracheboud J, Patnick J. Reporting of performance indicators of mammography screening in Europe. Eur J Cancer Prevent 2003;12:213-22.
46. Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int 2002;90:162-73.
47. Siebert U, Mühlberger N, Behrend C, Wasem J. PSA-Screening beim Prostatakarzinom. Systematischer gesundheitsökonomischer Review. Berichte aus der Schriftenreihe HTA des DIMDI Band 19, 2001, ISBN 3-7890-7165-X. Available from: http://gripsdb.dimdi.de/de/hta/hta_berichte/hta019_bericht_de. pdf
48. Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, et al. Cancer surveillance series: Interpreting trends in prostate cancer. Part I: Evidence of the effect of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 1999; 91: 1017.
49. Merrill RM, Bird JS. Effect of young age on prostate cancer survival: A population-based assessment (United States). Cancer Causes Control 2002;13:435-43.
50. Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, et al. Gender differences in stage-adjusted bladder cancer survival. Urology 2000;55:876-80.
51. th century: Most up-to-date estimates from the nationwide Finnish cancer registry. Br J Cancer 2001;85:367-71.
52. Bossard N, Velten M, Renontet L, Belot A, Maarouf N, Bouvier AM, et al. Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer 2007;43:149-60.